The Role of NURR1 in Metabolic Abnormalities of Parkinson's Disease

Overview

Journal Mol Neurodegener

Publisher Biomed Central

Specialties Molecular Biology
Neurology

Date 2022 Jun 27

PMID 35761385

Authors

Murad Al-Nusaif

Yuting Yang

Song Li

Cheng Cheng

Weidong Le

Affiliations

Soon will be listed here.

Abstract

A constant metabolism and energy supply are crucial to all organs, particularly the brain. Age-dependent neurodegenerative diseases, such as Parkinson's disease (PD), are associated with alterations in cellular metabolism. These changes have been recognized as a novel hot topic that may provide new insights to help identify risk in the pre-symptomatic phase of the disease, understand disease pathogenesis, track disease progression, and determine critical endpoints. Nuclear receptor-related factor 1 (NURR1), an orphan member of the nuclear receptor superfamily of transcription factors, is a major risk factor in the pathogenesis of PD, and changes in NURR1 expression can have a detrimental effect on cellular metabolism. In this review, we discuss recent evidence that suggests a vital role of NURR1 in dopaminergic (DAergic) neuron development and the pathogenesis of PD. The association between NURR1 and cellular metabolic abnormalities and its implications for PD therapy have been further highlighted.

Citing Articles

Manipulated mesenchymal stem cell therapy in the treatment of Parkinson's disease.

Ekrani S, Mahmoudi M, Haghmorad D, Kheder R, Hatami A, Esmaeili S Stem Cell Res Ther. 2024; 15(1):476.

PMID: 39696636 PMC: 11657756. DOI: 10.1186/s13287-024-04073-9.

Exploring transcriptomic mechanisms underlying pulmonary adaptation to diverse environments in Indian rams.

Gera R, Arora R, Chhabra P, Sharma U, Parsad R, Ahlawat S Mol Biol Rep. 2024; 51(1):1111.

PMID: 39485559 DOI: 10.1007/s11033-024-10067-w.

Advanced paternal age exacerbates neuroinflammation in offspring via m6A modification-mediated intergenerational inheritance.

Mao Y, Meng Y, Zou K, Qin N, Wang Y, Yan J J Neuroinflammation. 2024; 21(1):249.

PMID: 39367406 PMC: 11453047. DOI: 10.1186/s12974-024-03248-8.

Developmental origins of Parkinson's disease risk: perinatal exposure to the organochlorine pesticide dieldrin leads to sex-specific DNA modifications in critical neurodevelopmental pathways in the mouse midbrain.

Kochmanski J, Virani M, Kuhn N, Boyd S, Becker K, Adams M Toxicol Sci. 2024; 201(2):263-281.

PMID: 38995845 PMC: 11424889. DOI: 10.1093/toxsci/kfae091.

Kochmanski J, Virani M, Kuhn N, Boyd S, Becker K, Adams M bioRxiv. 2024; .

PMID: 38746441 PMC: 11092502. DOI: 10.1101/2024.04.26.590998.

References

Lashuel H, Overk C, Oueslati A, Masliah E . The many faces of α-synuclein: from structure and toxicity to therapeutic target. Nat Rev Neurosci. 2012; 14(1):38-48. PMC: 4295774. DOI: 10.1038/nrn3406. View

Albin R, Young A, Penney J . The functional anatomy of basal ganglia disorders. Trends Neurosci. 1989; 12(10):366-75. DOI: 10.1016/0166-2236(89)90074-x. View

Chu Y, Muller S, Tavares A, Barret O, Alagille D, Seibyl J . Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes. Brain. 2019; 142(11):3565-3579. PMC: 7962904. DOI: 10.1093/brain/awz296. View

Furuhashi M, Hotamisligil G . Fatty acid-binding proteins: role in metabolic diseases and potential as drug targets. Nat Rev Drug Discov. 2008; 7(6):489-503. PMC: 2821027. DOI: 10.1038/nrd2589. View

Bell S, Burgess T, Lee J, Blackburn D, Allen S, Mortiboys H . Peripheral Glycolysis in Neurodegenerative Diseases. Int J Mol Sci. 2020; 21(23). PMC: 7727792. DOI: 10.3390/ijms21238924. View

Pei L, Castrillo A, Chen M, Hoffmann A, Tontonoz P . Induction of NR4A orphan nuclear receptor expression in macrophages in response to inflammatory stimuli. J Biol Chem. 2005; 280(32):29256-62. DOI: 10.1074/jbc.M502606200. View

Lhonore A, Commere P, Ouimette J, Montarras D, Drouin J, Buckingham M . Redox regulation by Pitx2 and Pitx3 is critical for fetal myogenesis. Dev Cell. 2014; 29(4):392-405. DOI: 10.1016/j.devcel.2014.04.006. View

Poitelon Y, Kopec A, Belin S . Myelin Fat Facts: An Overview of Lipids and Fatty Acid Metabolism. Cells. 2020; 9(4). PMC: 7226731. DOI: 10.3390/cells9040812. View

Amoasii L, Holland W, Sanchez-Ortiz E, Baskin K, Pearson M, Burgess S . A MED13-dependent skeletal muscle gene program controls systemic glucose homeostasis and hepatic metabolism. Genes Dev. 2016; 30(4):434-46. PMC: 4762428. DOI: 10.1101/gad.273128.115. View

10.

Singh S, Mishra A, Mohanbhai S, Tiwari V, Chaturvedi R, Khurana S . Axin-2 knockdown promote mitochondrial biogenesis and dopaminergic neurogenesis by regulating Wnt/β-catenin signaling in rat model of Parkinson's disease. Free Radic Biol Med. 2018; 129:73-87. DOI: 10.1016/j.freeradbiomed.2018.08.033. View

11.

Kao S . Rescue of alpha-synuclein cytotoxicity by insulin-like growth factors. Biochem Biophys Res Commun. 2009; 385(3):434-8. DOI: 10.1016/j.bbrc.2009.05.089. View

12.

Jodeiri Farshbaf M, Forouzanfar M, Ghaedi K, Kiani-Esfahani A, Peymani M, Shoaraye Nejati A . Nurr1 and PPARγ protect PC12 cells against MPP(+) toxicity: involvement of selective genes, anti-inflammatory, ROS generation, and antimitochondrial impairment. Mol Cell Biochem. 2016; 420(1-2):29-42. DOI: 10.1007/s11010-016-2764-4. View

13.

Jao C, Hegde B, Chen J, Haworth I, Langen R . Structure of membrane-bound alpha-synuclein from site-directed spin labeling and computational refinement. Proc Natl Acad Sci U S A. 2008; 105(50):19666-71. PMC: 2605001. DOI: 10.1073/pnas.0807826105. View

14.

Gaugler M, Genc O, Bobela W, Mohanna S, Ardah M, El-Agnaf O . Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity. Acta Neuropathol. 2012; 123(5):653-69. DOI: 10.1007/s00401-012-0963-y. View

15.

Sharma S, Chorell E, Steneberg P, Vernersson-Lindahl E, Edlund H, Wittung-Stafshede P . Insulin-degrading enzyme prevents α-synuclein fibril formation in a nonproteolytical manner. Sci Rep. 2015; 5:12531. PMC: 4521159. DOI: 10.1038/srep12531. View

16.

Siddiqui A, Chinta S, Mallajosyula J, Rajagopolan S, Hanson I, Rane A . Selective binding of nuclear alpha-synuclein to the PGC1alpha promoter under conditions of oxidative stress may contribute to losses in mitochondrial function: implications for Parkinson's disease. Free Radic Biol Med. 2012; 53(4):993-1003. PMC: 3418424. DOI: 10.1016/j.freeradbiomed.2012.05.024. View

17.

Eells J, Misler J, Nikodem V . Reduced tyrosine hydroxylase and GTP cyclohydrolase mRNA expression, tyrosine hydroxylase activity, and associated neurochemical alterations in Nurr1-null heterozygous mice. Brain Res Bull. 2006; 70(2):186-95. DOI: 10.1016/j.brainresbull.2006.05.004. View

18.

Bendor J, Logan T, Edwards R . The function of α-synuclein. Neuron. 2013; 79(6):1044-66. PMC: 3866954. DOI: 10.1016/j.neuron.2013.09.004. View

19.

Lee K, Huh S, Lee S, Wu Z, Kim A, Kang H . Altered ER-mitochondria contact impacts mitochondria calcium homeostasis and contributes to neurodegeneration in vivo in disease models. Proc Natl Acad Sci U S A. 2018; 115(38):E8844-E8853. PMC: 6156612. DOI: 10.1073/pnas.1721136115. View

20.

van Horssen J, van Schaik P, Witte M . Inflammation and mitochondrial dysfunction: A vicious circle in neurodegenerative disorders?. Neurosci Lett. 2017; 710:132931. DOI: 10.1016/j.neulet.2017.06.050. View